Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: application to breast and ovarian tumors
- PMID: 9671178
- PMCID: PMC6807817
- DOI: 10.1002/(SICI)1098-2825(1998)12:4<250::AID-JCLA10>3.0.CO;2-U
Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: application to breast and ovarian tumors
Abstract
We have developed a simple and highly efficient method to detect deletions and insertions in the p53 gene. All 11 exons of the p53 gene were amplified along with a control sequence in four multiplex PCR reactions in the presence of fluorescein-labeled primers. The PCR products were resolved on an automated sequencing gel and the DNA fragments were detected by fluorescence. Using this method, we screened 7 DNA specimens from ovarian tumors, 19 from breast tumors, and 26 from normal breast tissues. No abnormality was found in any of the DNA samples extracted from the normal tissues. A 19 base pair deletion in exon 5 of the p53 gene was detected in one ovarian tumor. Insertions were identified in two breast and two ovarian tumors. The insertions were identical in 3 of these tumors and consisted of a 16 bp repeat within intron 3 of the p53 gene. It appears that the insertion within intron 3 may represent a hot spot for duplication of the normal sequence at that site.
Similar articles
-
Exon 5 of the p53 gene is a target for deletions in ovarian cancer.Clin Chem. 1998 Jan;44(1):72-7. Clin Chem. 1998. PMID: 9550561
-
Rapid sequencing of the p53 gene with a new automated DNA sequencer.Clin Chem. 1998 Jul;44(7):1397-403. Clin Chem. 1998. PMID: 9665415
-
Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines.Hum Genet. 1994 Jun;93(6):620-4. doi: 10.1007/BF00201559. Hum Genet. 1994. PMID: 8005584
-
Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments.Hum Mutat. 2002 Sep;20(3):218-26. doi: 10.1002/humu.10108. Hum Mutat. 2002. PMID: 12203994
-
Is it possible to diagnose malignancy from fluid in cystic ovarian tumors?Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):96-100. doi: 10.1016/j.ejogrb.2013.08.003. Epub 2013 Aug 9. Eur J Obstet Gynecol Reprod Biol. 2013. PMID: 24017961
Cited by
-
Statistical strategies to improve the efficiency of molecular studies of colorectal cancer prognosis.Br J Cancer. 2008 Dec 16;99(12):2001-5. doi: 10.1038/sj.bjc.6604792. Epub 2008 Nov 18. Br J Cancer. 2008. PMID: 19018265 Free PMC article.
References
-
- Lane, DP : p53, guardian of the genome. Nature 358: 15–16, 1992. - PubMed
-
- Vogelstein B, Kinzler KW: p53 function and dysfunction. Cell 70: 523–526, 1992. - PubMed
-
- Marx, J : How p53 suppresses cell growth. Science 262: 1644–1645, 1993. - PubMed
-
- El‐Deiry WS, Tokino T, Velculescu VE, et al.: WAF1, a potential mediator of p53 tumor suppression. Cell 7: 817–825, 1993. - PubMed
-
- Kastan MB, Zhan Q, El‐Deiry WS, et al.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia‐telangiectasia. Cell 71: 587–597, 1992. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous